Case Study: Mapping and Monitoring Biosimilar Clinical Activity for Branded Oncology and Inflammation Drugs in Korea, India and China
Gain insights into biosimilar clinical activities in Asia, which empowered our client to strategically position their branded drugs in cancer and inflammation treatment markets worldwide.